News
News
- Taurus Investment Holdings and Aegon Asset Management Announce ESG-Centric Decarbonization Venture
03/23/2022 / 13:00 - GlobeNewswire - $6.75m Mackenzie Scott Gift Boosts Bay Area Affordable Homebuilder
03/22/2022 / 16:01 - GlobeNewswire - NAI Global Announces International Market Trends Report on Commercial Real Estate
03/21/2022 / 14:00 - GlobeNewswire - Latest Research Evaluating VASCEPA® (Icosapent Ethyl) to be Presented at the American College of Cardiology’s 71st Annual Scientific Session
03/21/2022 / 13:30 - GlobeNewswire - DIFFA BY DESIGN TAKES CENTER STAGE IN NYC, MARCH 24-26, 2022
03/18/2022 / 22:43 - GlobeNewswire - Introducing Lettey, a New App that Leverages the Power of Social Networks to Help Renters Find—and Rent—an Apartment in NYC
03/16/2022 / 13:00 - GlobeNewswire - Dress for Success San Francisco Honors Groundbreaking “Bay Area Women in Power” Leading the Way to Support Others
03/14/2022 / 19:56 - GlobeNewswire - Ascendis Pharma A/S Announces Phase 3 PaTHway Trial of TransCon™ PTH in Adults with Hypoparathyroidism Met Primary and All Key Secondary Endpoints
03/13/2022 / 22:53 - GlobeNewswire - Dress for Success San Francisco Honors Groundbreaking “Bay Area Women in Power” Leading the Way to Support Others
03/10/2022 / 18:43 - GlobeNewswire - Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention
03/10/2022 / 14:47 - GlobeNewswire
Real-time